Protein-energy malnutrition worsens hospitalization outcomes of patients with pancreatic cancer undergoing open pancreaticoduodenectomy

Abstract

To assess the role of protein-energy malnutrition on perioperative outcomes in patients with pancreatic cancer undergoing open pancreaticoduodenectomy. We conducted a retrospective observational cohort study and investigated patients ≥ 18 years old with pancreatic cancer undergoing open pancreaticoduodenectomy within the National inpatient sample database during 2012–2014. The study population was divided into two groups based on the presence of protein-energy malnutrition. In-hospital mortality, length of stay, cost of hospitalization, and in-hospital complications were compared between the two groups. Logistic and linear regression analyses were used to adjust for potential confounders. A trend analysis was further conducted on the in-hospital outcomes. Of the 12,785 patients aged ≥ 18 years undergoing open pancreaticoduodenectomy during years 2012–2014, 9865 (77.0%) had no protein-energy malnutrition and 2920 (23.0%) had protein-energy malnutrition. Patients with protein-energy malnutrition were found to have significantly higher mortality rate, longer length of hospital stay, and higher total hospital cost compared to those without protein-energy malnutrition. The risks of gastroparesis, small bowel obstruction, intraoperative and postoperative hemorrhage, infectious complications, and several systemic complications were found to be significantly higher in the protein-energy malnutrition group in a multivariate regression model. A study of trends from 2009 to 2012 revealed an increasing prevalence of protein-energy malnutrition, a declining trend in mortality and length of stay and a stable total hospital cost in the protein-energy malnutrition group. Protein-energy malnutrition was found to be associated with higher mortality, longer length of hospital stay and greater hospital cost in pancreatic cancer patients undergoing open pancreaticoduodenectomy, as well as increased occurrence of various systemic complications. Attention should be paid to patients’ nutritional status, which can be corrected before surgery as an effective means to optimize postoperative results.

Pancreatic Ductal Adenocarcinoma: Update of CT-Based Radiomics Applications in the Pre-Surgical Prediction of the Risk of Post-Operative Fistula, Resectability Status and Prognosis

“…The current gold standard of assessing CR-POPF risk is based on intraoperative factors: pancreatic texture, pancreatic duct width, and BMI are established risk factors [124][125][126][127][128].…”

“…As AI-based models are strongly predictive, radiomic features from preoperative CT imaging related to clinical factors can help identify patients at high risk for postoperative pancreatic fistula following pancreatic head resection [137,138]. The current gold standard of assessing CR-POPF risk is based on intraoperative factors: pancreatic texture, pancreatic duct width, and BMI are established risk factors [124][125][126][127][128].…”

Impact of Preoperative Malnutrition on Patients with Pancreatic Neoplasms Post-Duodenopancreatectomy: A Retrospective Cohort Study

“…From a mechanical standpoint, there is an extrinsic compression of the stomach, abdominal esophagus, and first duodenal tract, influencing appetite and subsequent weight loss [ 10 ]. Preoperative malnutrition is one of the causes of complications in the postoperative period [ 11 , 12 ], and length of stay (LoS) is among the outcomes influenced by malnutrition conditions. Perioperative care has been supported since 2012 by Enhanced Recovery After Surgery (ERAS) guidelines to reduce postoperative complications, shorten hospital stays, and lower healthcare costs [ 13 ].…”

Nutritional Interventions during Chemotherapy for Pancreatic Cancer: A Systematic Review of Prospective Studies

“…Malnutrition’s prevalence varies between 33.7% and 70.6% in PC patients, while the presence of sarcopenia has a great impact on this population, reaching 74% of PC patients according to some studies [ 8 , 11 ]. Malnutrition and sarcopenia are associated with an increased risk of chemotherapy-related toxicity (CIT), postoperative morbidity, poorer survival, and reduced Quality of Life (QoL) [ 12 , 13 , 14 ]. Thus, nutritional support during CHT may play a very special role in these patients [ 15 , 16 ].…”